De Lorenzo F, Monticelli A, Cocozza S, De Simone B, Rubba P
Institute of Internal Medicine and Metabolic Diseases, Policlinico, Naples, Italy.
Clin Investig. 1994 Jun;72(6):435-41. doi: 10.1007/BF00180517.
The relationships between some genetic markers, as evaluated by DNA analysis, and ultrasound evidence of extracoronary athero-sclerosis, as detected by ultrasound methods, were evaluated in 39 myocardial infarction survivors of middle age and in 40 healthy controls of comparable age. Coronary heart disease (CHD) patients showed higher levels of triglycerides (P = 0.01) and greater number of exsmokers (P = 0.004). Carotid stenoses (> 15%) were detected in ten CHD patients and in two controls; iliac stenoses (> 15%) or abnormal ankle/arm ratio (< 0.97) were found in ten CHD patients and in one control; the scores of vascular disease severity in the myocardial infarction survivors were higher (Mann-Whitney test) than in controls (P < 0.01). Molecular genetic analysis of SstI restriction fragment length polymorphism (RFLP) of the apolipoprotein (apo) AI-CIII cluster and of the apo B gene demonstrated a higher frequency of the S2 allele (SstI RFLP) in coronary patients than in controls (P = 0.04) and no significant differences in the frequencies of XbaI RFLP of the apo B gene between patients and controls. The relative risk of myocardial infarction associated with an abnormal vascular score (> 8) or with the presence of the rare allele S2 (SstI apo AI-CIII polymorphism) was estimated by odds ratios. The lower 95% limits of odds ratios were above 1 (indicating significant increase in the relative risk of myocardial infarction) both in the case of vascular score and that of SstI RFLP. These associations were independent of one another and of triglyceride levels. SstI RFLP association with CHD disappeared after adjustment for smoking habits.(ABSTRACT TRUNCATED AT 250 WORDS)
通过DNA分析评估的一些基因标记与通过超声方法检测的冠状动脉外动脉粥样硬化的超声证据之间的关系,在39名中年心肌梗死幸存者和40名年龄相仿的健康对照者中进行了评估。冠心病(CHD)患者的甘油三酯水平较高(P = 0.01),既往吸烟者数量更多(P = 0.004)。在10名冠心病患者和2名对照者中检测到颈动脉狭窄(> 15%);在10名冠心病患者和1名对照者中发现髂动脉狭窄(> 15%)或异常踝/臂比(< 0.97);心肌梗死幸存者的血管疾病严重程度评分高于对照组(曼-惠特尼检验)(P < 0.01)。对载脂蛋白(apo)AI-CIII簇和apo B基因的SstI限制性片段长度多态性(RFLP)进行分子遗传学分析显示,冠心病患者中S2等位基因(SstI RFLP)的频率高于对照组(P = 0.04),而患者与对照组之间apo B基因的XbaI RFLP频率无显著差异。通过比值比估计与异常血管评分(> 8)或罕见等位基因S2(SstI apo AI-CIII多态性)存在相关的心肌梗死相对风险。血管评分和SstI RFLP情况下比值比的较低95%置信区间均高于1(表明心肌梗死相对风险显著增加)。这些关联相互独立且与甘油三酯水平无关。调整吸烟习惯后,SstI RFLP与冠心病的关联消失。(摘要截选至250词)